U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT06907628) titled 'A Trial of SHR-3792 Injection in Patients With Advanced Solid Tumors' on March 26.
Brief Summary: The study is being conducted to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of SHR-3792 injection monotherapy for patients with advanced solid tumors, and to explore the reasonable dosage of SHR-3792 injection monotherapy for patients with advanced solid tumors.
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Tumors
Intervention:
DRUG: SHR-3792 Injection
SHR-3792 injection.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., ...